Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers...
Pro-Dex (NASDAQ:PDEX) Upgraded by Zacks Research to "Strong-Buy" Rating
Pro-Dex CFO Alisha Charlton disposes of 2,300 common shares worth $140,755
Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS
Pro-Dex shares are trading higher after the company reported better-than-expected Q4 financial results.